Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00426777
Recruitment Status : Completed
First Posted : January 25, 2007
Last Update Posted : February 3, 2012
Information provided by (Responsible Party):
CMX Research

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2009
  Actual Study Completion Date : February 2009